62698-55-9,
AC1L3C9I,
Glycine, N,N'-((3-oxo-1(3H)-isobenzofuranylidene)bis((6-hydroxy-2-methyl-5-(1-methylethyl)-3,1-phenylene)methylene))bis(N-(carboxymethyl)-, sodium salt (1:4),
Glycine, N,N'-((3-oxo-1(3H)-isobenzofuranylidene)bis((6-hydroxy-2-methyl-5-(1-methylethyl)-3,1-phenylene)methylene))bis(N-(carboxymethyl)-, tetrasodium salt,
3 inverted exclamation marka,3 inverted exclamation marka-Bis[N,N-di(carboxymethyl)aminomethyl]thymolphthalein,
N,N'-[(3-Oxoisobenzofuran-1(3H)-ylidene)bis[[6-hydroxy-2-methyl-5-(1-methylethyl)-3,1-phenylene]methylene]]bis[N-(carboxymethyl)glycine]tetrasodium salt,
tetrasodium 2-[[5-[1-[3-[[bis(2-oxido-2-oxoethyl)amino]methyl]-4-hydroxy-2-methyl-5-propan-2-ylphenyl]-3-oxo-2-benzofuran-1-yl]-2-hydroxy-6-methyl-3-propan-2-ylphenyl]methyl-(2-oxido-2-oxoethyl)amino]acetate,
Thymolphthalein-2 inverted exclamation marka,2 inverted exclamation marka-bis(methyliminodiacetic acid sodium salt),
Thymolphthalexon,
C38H44N2O12.4Na,
CID112917,
C38-H44-N2-O12.4Na,
CID 112917,
Glycine, N,N'-[(3-oxo-1(3H)-isobenzofuranylidene)bis[[6-hydroxy-2-methyl-5-(1-methylethyl)-3,1-phenylene]methylene]]bis[N-(carboxymethyl)-, tetrasodium salt,
Glycine, N,N'-[(3-oxo-1(3H)-isobenzofuranylidene) bis[[6-hydroxy-2-methyl-5-(1-methylethyl )-3,1-phenylene]methylene]]bis[N-(carboxymethy l)-, tetrasodium salt,
Glycine, N,N'-[(3-oxo-1(3H)-isobenzofuranylidene)bis[[6-hydroxy-2-methyl-5-(1-methylethyl)-3,1-phenylene]methylene]]bis[N-(carboxymethyl)-, sodium salt (1:4),